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INTRODUCTION 
 
Hemoptysis is defined as bleeding that originates from the lower respiratory 
tract. (1)  In developing countries, the majority of cases are due to tuberculosis. (2)  
Massive hemoptysis is a major clinical and surgical problem with a mortality of 
80%, which is most often related to asphyxiation. (3,4) Conservative management 
of massive hemoptysis carries a mortality rate of 50%–100% (5) and the mortality 
is up to 35% even in patients undergoing operation. (6)  Because of poor 
pulmonary reserve and other medical comorbid conditions, most patients with 
massive hemoptysis are not ideal surgical candidates. ( 4,5)  Therapeutic bronchial 
artery embolization is a good treatment adjunct to control bronchial bleeding and 
reduces the need for high-risk emergency lung resections. (7)  
It has become an established procedure in the management of massive and 
recurrent hemoptysis; its use was first reported in 1973 by Remy et al. (8) It is a 
useful therapy to control both acute and chronic hemoptysis (9) and is an effective 
method for management of massive hemoptysis in developing countries and has a 
low complication rate. (10,11)  BAE may help to avoid surgery in patients who are 
not good surgical candidates. Should hemoptysis recur in these patients, repeat 
embolization can be performed safely. (9)  Surgery remains the procedure of 
choice in the treatment of massive hemoptysis caused by specific conditions, such 
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as hydatid cyst, thoracic vascular injury, bronchial adenoma, and aspergilloma that 
is resistant to other therapies. (12) Even in surgical candidates, BAE is effective in 
preparing the patient for elective rather than high-risk emergency surgery. (7)  
Various nonbronchial systemic arteries, as well as pulmonary arteries, may 
also contribute to hemoptysis, and their implication is dependent on the underlying 
pathologic condition. (13-18) Nonbronchial systemic collateral vessels must be 
particularly suspected when there is evidence of coexistent pleural disease. (11,19) 
Recognition and occlusion of nonbronchial systemic collaterals providing blood to 
hypervascular pulmonary lesions is essential for successful percutaneous 
embolotherapy of hemoptysis. (2,17-20)  
Prior to embolization, the interventional radiologist needs to be aware of the 
side of the bronchial artery bleeding, and the most likely source of bleeding has to 
be identified to determine which vessel(s) is to be occluded. Since the bronchial 
circulation is the most frequent source of hemoptysis, embolization of bronchial 
arteries is usually the favored therapeutic option to stop the bleeding. (11,21) 
Recent important technologic advances in CT, particularly the development of 
multi– detector row CT, have introduced a comprehensive, noninvasive method of 
evaluating the entire thorax, allowing detailed assessment of the mediastinum and 
lung parenchyma. (11,21)  
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Multi–detector row helical CT angiography can also help in the planning of 
a focused and efficient nonbronchial systemic artery embolization. It provides a 
precise road map for the interventional radiologist  in performing an endovascular 
treatment  for hemoptysis. The availability of this information before the patient 
arrives in the angiographic suite is expected to help reduce the examination time by 
facilitating attempts at direct selective catheterization of the arteries to be 
occluded. (21) 
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AIM OF THE STUDY 
 
The purpose of the present study is to retrospectively evaluate the depiction 
of bronchial and nonbronchial systemic arteries with multi–detector row helical CT 
compared with conventional angiography in patients undergoing endovascular 
treatment of hemoptysis. 
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REVIEW OF LITERATURE 
 
1. LIFE THREATENING HEMOPTYSIS: 
Massive hemoptysis is a major clinical and surgical problem with a mortality 
of 80%, which is most often related to asphyxiation. (3) There are various 
definitions for massive hemoptysis in literature.  It has been described as the 
expectoration of an amount of blood ranging from 50 mL to more than 1,000 mL 
over a period of 24 hours, and the most widely used criterion is the production of 
300–600 mL per day. (4,5,6,7,12,22,23) However, depending on the ability of the 
patient to maintain a patent airway, a lifethreatening condition may be caused by a 
rather small amount of hemorrhage. Thus, a more functional definition of 
“massive” as an amount sufficient to cause a life-threatening condition should be 
used in deciding whether to undertake interventional management . (12,24,25) 
Asphyxiation and less commonly exsanguination are the usual causes of death.(27) 
Any assessment of the severity of hemoptysis must take into account the 
patient’s cardiorespiratory status, bleeding activity, the possibility of “internalized” 
(eg, intrapleural, intrapericardial, or intracavitary) bleeding, and the risk of 
recurrent bleeding. In particular, the recognition of “sentinel bleeding” heralding 
imminent major hemorrhage is of critical importance but is often difficult on the 
basis of clinical findings alone. (28,29) The chronicity of the disease is an 
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important aspect in selecting a patient for radiological intervention. It is in this 
clinical setting that bronchial artery hypertrophy occurs, facilitating transcatheter 
therapy. Without hypertrophy, bronchial artery embolization is less likely to be of 
benefit.  
Chronic inflammatory lung disease is the predominant cause of severe 
hemoptysis.  (2,10,26) In the non-Western world, pulmonary tuberculosis is the 
most common underlying cause of massive hemoptysis. Massive hemoptysis in 
patients with tuberculosis is reported usually in association with cavitary disease or 
aspergiloma. However, there are case reports of sputum positive tuberculosis with 
massive recurrent tuberculosis without evidence of any cavitary disease. (37) In  
patients with tuberculosis, hemoptysis is a major cause of death, even in the era of 
effective antituberculous therapy. (38) Those with mycetoma suffer the highest 
recurrence of bleeding even after embolization. (39) Bronchogenic carcinoma and 
chronic inflammatory lung diseases due to bronchiectasis, cystic fibrosis, or 
aspergillosis are the more prevalent causes of hemoptysis in Western countries. 
(4,5,12,30) Other causes of hemoptysis include pulmonary malignancy, 
arterioarterial shunts, pulmonary trauma, pulmonary arteriovenous malformation, 
bronchial artery aneurysm, pulmonary pseudosequestration, dieulafoy disease, 
congenital heart disease, after Glenn and Blalock anastomoses, interstitial disease, 
pulmonary hypertension and pulmonary embolism. (9,17,23,31-36,40-44,47,48) A 
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pulmonary arterial source should also be considered when bleeding continues after 
technically successful bronchial artery and nonbronchial systemic arterial 
embolization.  The pulmonary arteries may also be the source of hemorrhage in 
cases of direct invasion by neoplastic disease or by necrotizing inflammatory 
disorders such as tuberculosis (15,40) and can be treated by embolization (45,46) 
Cryptogenic hemoptysis (hemoptysis for which no cause has yet been 
identified) is a diagnosis of exclusion and has a reported prevalence of 
approximately 3%–42%. (50-53) It occurs most often in patients who smoke, and 
its importance lies in the reported statistic that 6% of such patients will present 
with unresectable lung carcinoma within the next 3 years. (52,54) 
 
2.  RELEVANT ANATOMY 
The lungs are supplied by a dual arterial vascular system composed of (a) 
the pulmonary arteries, which account for 99% of the arterial blood supply to the 
lungs and take part in gas exchange; and (b) the bronchial arteries, which are 
responsible for providing nourishment to the supporting structures of the airways 
and of the pulmonary arteries themselves (vasa vasorum) but do not normally take 
part in gas exchange. (55) The bronchial vasculature feeding the intrapulmonary 
airways is situated close to the pulmonary arteries at the level of the vasa vasorum, 
and histologically the two systems are connected by anastomoses between the 
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systemic and pulmonary capillaries. (56) Bronchial artery branches supply the vasa 
vasorum of the aorta, pulmonary artery and vein as well as the diaphragmatic and 
mediastinal portions of the visceral pleural, the middle third of the esophagus, 
trachea, extra- and intrapulmonary airways, bronchovascular bundles, nerves, 
supporting structures, regional lymph nodes, and lymph nodes. Most of the venous 
return occurs through the pulmonary veins by way of bronchial pulmonary 
anastomoses. (55,57)  
There is an extensive potential anastomotic network between the bronchial 
arteries and other structures in the mediastinum, spine, head, and neck. These 
bronchial pulmonary arterial anastomoses may become prominent in the abnormal 
lung, reflecting either chronic inflammation or pulmonary hypertension. (17,58) 
This communication between the bronchial and pulmonary arteries contributes to a 
normal right-to-left shunt that accounts for 5% of cardiac output. (55) 
The bronchial arteries have variable anatomy in terms of origin, branching 
pattern, and course. (4, 59) In over 70% of the general population, the bronchial 
arteries arise from the descending thoracic aorta, most commonly between the 
levels of T5 and T6. There are normally one or two bronchial arteries supplying 
each lung, arising either independently or from a common trunk. (3, 60) 
On the right side, an intercostobronchial trunk usually exists, arising from 
the right posteromedial aspect of the aorta and coursing cranially before giving rise 
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to one or more posterior intercostal arteries and a right bronchial arterial 
component. This component turns sharply in the caudal direction to the level of the 
right main bronchus, where it ramifies in the lung parenchyma parallel to the 
bronchus and more distal airways. The left bronchial artery usually arises from the 
anterior aspect of the descending thoracic aorta, either singly (30.5% of cases) or 
as a common trunk with a second right bronchial artery (25%), before coursing 
toward the left hilum and perhaps through the aortopulmonary window. (21, 61)  
In 70% of cases, there are two left bronchial arteries in addition to the right 
intercostobronchial trunk. (60) Bronchial arteries that arise in the expected location 
from the descending thoracic aorta between the levels of T5 and T6 are called 
orthotopic bronchial arteries. Anomalous bronchial arteries, defined as bronchial 
arteries that originate outside the T5 through T6 range, are found in 8.3%–21% of 
cases of hemoptysis. (43, 62) 
The bronchial arteries have highly tortuous but predictable trajectories that 
can easily be analyzed with a thorough knowledge of bronchial arterial anatomy.  
Cauldwell, in 1948, described four common variations: (Fig 1) type 1—two left 
and single right bronchial arteries (41 percent); type 2—single bronchial arteries 
bilaterally (21 percent); type 3—two left and two right bronchial arteries arising 
separately or in various combinations (21 percent); and type 4—single left and two 
right bronchial arteries (10 percent).  (60)  In 1985, Uflacker and colleagues 
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classified bronchial artery variations into ten types (Fig 2) and reported common 
bronchial trunks in 43% of patients (3) The four most common types in Uflacker’s 
study can be seen in Figure 3. The bronchial arteries can drain into the Pulmonary 
artery, Pulmonary vein or into the bronchial vein. (57) In adults, normal bronchial 
arteries measure less than 1.5 mm in diameter at their origin and 0.5 mm at their 
point of entry into a bronchopulmonary segment. (55) 
Anomalous bronchial arteries, defined as bronchial arteries that originate 
outside the T5 through T6 range, are found in 8.3%–21% of cases of hemoptysis.  
(21, 60,62) They are easily overlooked during bronchial artery embolization, even 
when complemented with arch aortography. (63)  As many as 20 percent of 
bronchial arteries have anomalous origins from sites other than the aorta, and 
approximately 10 percent originate from the concave or convex surfaces of the 
aortic arch. Other aberrant origins of the bronchial arteries include the subclavian, 
thyrocervical, internal mammary, innominate, pericardiophrenic, superior 
intercostal, abdominal aorta, and inferior phrenic arteries.  (11, 21, 60, 62,64-66) 
Recognition and occlusion of nonbronchial systemic collaterals providing 
blood to hypervascular pulmonary lesions is essential for successful percutaneous 
embolotherapy of hemoptysis. (17, 18).   These arteries provide systemic collateral 
vessels that reach the lung parenchyma via the inferior pulmonary ligaments (in the 
case of the inferior phrenic arteries) or transpleural adhesions (in the case of 
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branches from the intercostal and supraaortic arteries) and that form anastomoses 
with the pulmonary arterial circulation in regions of inflammation or neoplasia. 
(9,11,17,63,67,68) These nonbronchial systemic vessels must be suspected when 
there is pleural disease adjacent to the pulmonary parenchymal lesion. (19, 69) 
A pulmonary arterial source should also be considered when bleeding 
continues after technically successful bronchial artery and nonbronchial systemic 
arterial embolization. (15) Peripheral pulmonary artery pseudoaneurysms occur in 
up to 11% of patients undergoing bronchial angiography for hemoptysis. (45) 
  In disease entities that cause diminished pulmonary arterial blood flow such 
as cyanotic congenital heart disease, chronic thromboembolic disease, and 
vasculitides such as Takayasu arteritis, shunting can occur from coronary arteries 
to pulmonary arteries via the bronchial arteries. (70,71)  Coronary-to bronchial  
arterial anastomoses normally arise from the atrial branches of both coronary 
arteries. Such shunting may be involved in the “pulmonary steal” syndrome that 
manifests in some patients as classic angina-like symptoms in the presence of 
angiographically normal coronary arteries. (72) 
Coronary-to-bronchial artery anastomoses are most often identified in the region of 
the retrocardiac “bare areas” of the heart, where the relatively wide pericardial 
reflections permit the development of communications between the coronary and 
extracoronary arteries. (73) Conversely, in certain situations atherosclerotic 
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coronary artery disease can promote the development of bronchial-to-coronary 
arterial shunting.(74) 
The two kinds of spinal arteries which may be seen at bronchial and 
intercostal angiography during BAE are the radicular arteries and anterior 
medullary arteries.  Dorsal and ventral radicular arteries are small vessels that arise 
from segmental spinal arteries and supply the dorsal and ventral roots. (75)  The 
anterior spinal artery originates from branches of the intracranial segments of the 
vertebral arteries and receives supply from anterior radiculomedullary branches of 
intercostal and lumbar arteries along its length.  As many as six to eight 
contributing branches to the anterior spinal artery may exist, and each has a 
characteristic course resembling a hairpin loop. The largest anterior medullary 
branch (the artery of Adamkiewicz) has a variable origin from the T5 to L5 level 
but is most commonly found at the T8 to L1 level. (75-77) The right superior 
intercostal artery and right bronchial artery may share a common trunk and supply 
a branch to the anterior spinal artery . Left bronchial arteries rarely supply the 
anterior spinal artery. The posterior portion of the cord is supplied by a pair of 
posterior spinal arteries that course along the posterolateral surface of the spinal 
cord. These vessels are fed by posterior radicular arteries arising from intercostal 
and lumbar arteries and are much shorter and smaller than the anterior 
radiculomedullary arteries. (76) 
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3. PATHOPHYSIOLOGY OF HEMOPTYSIS 
Chronic inflammatory disorders such as bronchiectasis, chronic bronchitis, 
and chronic necrotizing infections (in particular, tuberculosis and mycotic lung 
disease) are associated with the release of angiogenetic growth factors such as 
vascular endothelial growth factor and angiopoietin 1, leading to 
neovascularization and vascular remodeling as well as an increase in the collateral 
supply from nearby systemic vessels.  Such newly formed collateral vessels are 
usually fragile and “leaky” and prone to rupture. (78,79) 
In certain situations, the thin-walled capillary communications between the 
high-pressure systemic bronchial arterial system and the lowerpressure pulmonary 
arterial system can vasodilate and enlarge. Conditions causing reduced pulmonary 
arterial perfusion such as chronic thromboembolic disease and vasculitic disorders, 
in which there is a reduction in pulmonary arterial supply distal to the emboli, can 
lead to a gradual increase in the bronchial arterial contribution ), thereby increasing 
the importance of bronchialto- pulmonary artery anastomoses in regions of the 
lung that are deprived of their pulmonary arterial blood flow. (55,70,80-83) 
The anastomotic vessels, which are subjected to increased systemic arterial 
pressure, are often thin walled and prone to rupture into the alveoli or bronchial 
14 
 
airways, giving rise to hemoptysis. Chronic inflammation can also lead to an 
increase in systemic arterial blood flow. (17,84)  
In 95% of cases of hemoptysis, the systemic arterial system is the origin of 
the bleeding. (11,85)  In a minority of cases (5%), massive hemoptysis may 
originate with the aorta (eg, aortobronchial fistula, ruptured aortic aneurysm) or the 
systemic arterial supply to the lungs. (86-88)  
 
4.  EVALUATION OF HEMOPTYSIS 
The current standing of the various imaging modalities for evaluation of life 
threatening hemoptysis is listed below: 
 
A) CHEST RADIOGRAPH 
Conventional radiography is a basic study and is readily available even 
under emergency conditions. It may be helpful in diagnosing and localizing 
pneumonia, acute or chronic pulmonary tuberculosis, bronchogenic cancer, or lung 
abscess. (89) However, radiographic findings are normal or nonlocalizing in 17%–
81% of patients with hemoptysis.(24,50,89-92) Chest radiograph may correlate 
well with angiographic findings if there is one lobar lesion, but multiple lobar 
lesions showed no correlation between the two modalities.(93) Pleural thickening 
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can be noted at chest radiography which negatively influences the long-term 
success rate of BAE. (94) 
 
B) BRONCHOSCOPY 
Bronchoscopy has long been considered by chest clinicians to be the primary 
method for diagnosis and localization of hemoptysis. (95,96) The diagnostic 
accuracy of FOB in patients with hemoptysis and normal chest radiographs is low, 
ranging from 0% to 31% . (50,89,91,97,98) Bronchoscopy, performed with either a 
rigid or a flexible fiberoptic endoscope, is useful in diagnosing active hemorrhage 
and has been stated to be useful in controlling the airway in patients with 
catastrophic hemorrhage. (96,99) FOB has some disadvantages in the diagnosis 
and localization of massive, active hemoptysis. It is difficult to localize the 
bleeding site with FOB in patients with massive hemoptysis because of excessive 
blood in the bronchi.  (24) Furthermore, irritation of the bronchial mucosa caused 
by lavage or by the endoscope itself can lead to recurrent bleeding. (24,100) 
 
C) SINGLE DETECTOR CT 
Possible underlying causes of hemoptysis that are identifiable on axial CT 
scans obtained with lung parenchymal window settings include bronchiectasis, 
lung carcinoma, acute and chronic lung infections (in particular, tuberculosis and 
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aspergillosis), and cardiogenic pulmonary edema. In patients with extensive 
bilateral disease or equivalent findings, the site of hemorrhage can usually be 
localized on the basis of the presence of liquified material in segmental and lobar 
bronchi and hazy consolidation or ground-glass infiltrates in the lung parenchyma, 
findings that represent intraalveolar hemorrhage. The accurate localization of the 
site of bleeding is important both for possible future lung resection and prior to 
endovascular therapy, for which identification of the specific vessels that require 
embolization is necessary. The consequences of hemorrhage into the airways and 
lung parenchyma may also mask subtle underlying disease. (49,50,101) 
  CT findings can suggest a specific diagnosis in 50% of patients in whom 
FOB findings are nondiagnostic and in 39%–88% of patients in whom chest 
radiographs are nondiagnostic. (89,90,91,101) CT can also help localize the site of 
bleeding in 63%–100% of patients with hemoptysis, a rate that is higher than that 
for FOB. (24,92) It has been stated that CT and FOB are not competitive but 
complementary tools for assessing patients with hemoptysis, and indeed, the 
combined use of FOB and CT does yield the best results in evaluating hemoptysis. 
(92) However, many researchers are currently suggesting that CT should be 
performed prior to bronchoscopy in all patients with hemoptysis.  (12,89-91)  
Published studies on the efficacy of single– detector row spiral CT have 
already demonstrated the capacity of this imaging technique to help predict the site 
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of bleeding as accurately as bronchoscopy and to help detect underlying disease 
with high sensitivity. (50,100) More recently, Yoon et al have evaluated the 
accuracy of single– detector row helical CT in helping to predict the presence of a 
nonbronchial systemic arterial supply in patients with massive hemoptysis, but 
they did not evaluate the clinical effect of CT findings in therapeutic decisions. 
(20) 
 
D) MULTIDETECTOR CT 
Urgent evaluation with thoracic CT angiography can help accurately identify 
the source and predisposing causes of hemoptysis and the effects of hemorrhage on 
the lungs. (49) Multi–detector row CT provides extended volume coverage with 
higher image resolution and even greater scanning speed.  (103,104) 
The aims of multi– detector row CT in the evaluation of hemoptysis are 
threefold: (a) to depict underlying disease with high sensitivity by means of 
detailed images of the lung parenchyma and mediastinum, and in particular to help 
detect early carcinoma; (b) to help assess the consequences of hemorrhage into the 
alveoli and airways, which may cause immediate clinical concerns as well as mask 
subtle underlying abnormalities; and (c) to provide a detailed “road map”of the 
thoracic vasculature by means of two-dimensional (2D) maximum-intensity-
projection (MIP) reformatted images and three-dimensional (3D) reconstructed 
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images. Such road maps are of great use to both the interventional radiologist 
anticipating arterial embolization and the thoracic surgeon contemplating surgery. 
(49) Multi–detector row helical CT has the ability to scan the entire thorax with a 
thin collimation, thus enabling the identification of bronchial arteries not only of 
orthotopic origin but also of ectopic origin.   
 
i) ASSESSMENT OF LUNG PARENCHYMA AND PLEURA 
MDCT can accurately evaluate the lung parenchymal diseases which might 
be the cause for hemoptysis.  Since it is fast, there is no need for breath holding 
also.  Various diseases which can be detected on MDCT are cavitary disease, 
bronchiectasis, aspergilloma, consolidation, interstitial disease and fibrosis. Pleural 
thickening of more than 3 mm and tortuous enhancing vascular structures within 
hypertrophic extrapleural fat seen at contrast enhanced CT are signs of 
nonbronchial systemic arterial supply in patients with massive hemoptysis. (11,20) 
In the presence of pleural thickening, nonbronchial systemic feeder vessels that 
originate from various arteries (eg, intercostals artery, branches of the subclavian 
and axillary arteries, internal mammary artery, inferior phrenic artery may develop 
along the pleural surface and become enlarged as a result of the  inflammatory 
process. (4,17,39,67,69) 
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ii) CT OF BRONCHIAL ARTERIES 
The site of origin and distribution of bronchial arteries are analyzed on 
transverse CT scans, maximum intensity projections and volume-rendered images. 
(105) CT interpretation focused on the evaluation of bronchial arteries ipsilateral to 
the side of bleeding is done by recording the following parameters: (a) the site of 
the ostium of the bronchial artery (or arteries), which is coded as orthotopic when 
the artery was originating from the descending aorta between the levels of the T5 
and T6 vertebrae or ectopic when identified at a level of the descending aorta other 
than the expected origin (i.e., outside levels T5- T6), such as the level of the aortic 
arch or from any aortic collateral vessel; (b) the origin of orthotopic bronchial 
arteries, which is further analyzed and included a systematic analysis of its location 
on the wall of the descending aorta (i.e., posterior, medial, anterior, or lateral) and 
its position relative to the tracheal carina; (c) the bronchial artery diameter, which 
is coded as enlarged when greater than 1.5 mm  and (d) the total number of 
bronchial arteries per side.  (21,80,106,107) 
In adults, normal bronchial arteries measure less than 1.5 mm in diameter at 
their origin and 0.5 mm at their point of entry into a bronchopulmonary segment. 
(55) The primary locations of enlarged bronchial arteries at CT are the retro 
esophageal area, retro- tracheal area, retro bronchial area, posterior wall of the 
main bronchus, and aortopulmonary window. Mediastinal lymph nodes, the azygos 
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vein, and an enhancing esophageal wall can mimic the bronchial arteries at CT. 
(108) The presence of calcifications of the aortic wall does not hamper the analysis 
of bronchial arteries.  Both the site of the origin of the bronchial artery and its hilar 
path can be precisely identified.  Both transverse CT scans and three dimensional 
reconstructions are required for accurate evaluation of bronchial arteries. Although 
curved reformations provide complementary information for most right orthotopic 
bronchial arteries, left bronchial arteries are not adequately demonstrated because 
of their short mediastinal length. Three-dimensional images were found to be 
superior to transverse CT scans in depicting the ectopic origin of the bronchial 
arteries, which enabled the interventional radiologists to perform successful 
embolization after direct catheterization of the ectopic vessel in every case. (21) 
Bronchial arteries of anomalous origin are easily overlooked during bronchial 
artery embolization, even when complemented with arch aortography but are well 
depicted with extended thoracic CT angiography that includes the base of the neck 
and the upper abdomen.  (63) 
iii) CT OF NONBRONCHIAL SYSTEMIC ARTERIES 
Multi–detector row helical CT angiography can help in the planning of a 
focused and efficient nonbronchial systemic artery embolization. (11,21) CT 
features suggestive of a nonbronchial systemic arterial supply are recorded for each 
hemithorax in each patient together with a specific evaluation of the pulmonary 
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circulation in the relevant area. For each nonbronchial artery considered in the 
present investigation, depiction of its ostium and recognition of its course toward 
the adjacent lung parenchymal zone are analyzed on transverse CT scans and 
three-dimensional images to determine if CT angiography has the ability in helping 
to evaluate this vessel.  The following features were considered to be suggestive of 
a nonbronchial systemic arterial supply as a source of hemoptysis: (a) abnormal 
enlargement of one or several of the branches of the subclavian and axillary 
arteries, particularly the internal mammary artery and its branches, the intercostal 
arteries, and the inferior phrenic arteries, and (b) the enlarged nonbronchial 
systemic arteries seen with or without the concurrent presence of pleural 
thickening and pulmonary abnormalities. (21) 
Two CT features were considered to be indirect predictors of a nonbronchial 
systemic arterial supply: (a) pleural thickness of more than 3 mm adjacent to the 
parenchymal lesion and (b) enhancing vascular structures within the extrapleural 
fat layer. In the determination of a nonbronchial systemic arterial supply, CT had a 
sensitivity of 80%, specificity of 84%, positive predictive value of 73%, negative 
predictive value of 91%, and accuracy of 84%. Sensitivity was highest for 
predicting the branches of subclavian and axillary arterial supply and was lowest 
for predicting the internal mammary arterial supply. Specificity and accuracy were 
highest for predicting the intercostal arterial supply.  
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iv) CT OF PULMONARY VESSELS 
Rasmussen aneurysms, representing fragile pulmonary arterial 
pseudoaneurysms arising within areas of tuberculous inflammation, may be 
responsible for sentinel bleeding prior to catastrophic hemorrhage and can be 
identified on contrast-enhanced CT scans as avidly enhancing nodules located 
within the walls of tuberculous cavities. (109-111) 
 
v) CT DETECTION OF SPINAL SUPPLY 
At contrast-enhanced thoracic CT angiography for the evaluation of 
hemoptysis prior to embolization therapy, it may be possible to visualize the artery 
of Adamkiewicz; however, the fine caliber of this artery and the possibility of 
mistaking it for an anterior spinal vein make it difficult to identify with certainty.  
(112) The AKA commonly originates from the left side. (113) By using the CT 
angiographic criteria reported by Takase et al for the recognition of the 
Adamkiewicz artery , the anterior spinal artery is searched for as a thin enhanced 
vessel on the midline ventral surface of the spinal cord, with a typical hairpin curve 
on coronal and sagittal MIPs of the cervicothoracic region. (112) CT angiography 
could represent a useful complementary means to prevent spinal cord ischemia 
when it is performed in association with the monitoring of somatosensory evoked 
potentials, a technique routinely used in our clinical practice. (114.115)  
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E) CONVENTIONAL ANGIOGRAPHY 
i) ANGIOGRAPHY TECHNIQUE 
Arterial access is most commonly achieved via common femoral artery 
puncture by modified Seldinger’s technique through which a sheath is inserted. If 
the patient is obese or if the iliac vessels are markedly tortuous, a long sheath is 
used that extends into the aorta. A variety of selected catheter curves can be used 
for subselective catheterization. When there is a low aortic arch or if the bronchial 
artery originates from the arch, a reverse-curve catheter may fail to adequately 
probe the aortic wall. The apex of the reverse-curve catheter will lie partially 
within the transverse arch, tilting the catheter and making catheterization of more 
proximately located bronchial arteries impossible. In these circumstances, forward-
looking catheters, such as the cobra, H1H, or RC shapes, can be used successfully. 
In general, 5.0 or 5.5 French catheters are initially used, reserving the larger 6.5 to 
7.0 French catheters for a particularly tortuous vascular system where increased 
steerability is required.  
The bronchial artery search is begun at the T5 to T6 level. (60) In addition to 
the location of the ostium of orthotopic bronchial arteries on the surface of the 
aortic wall, the caudocranial level of origin is also analyzed. Whereas most authors 
describe the origins of bronchial arteries based on the level or range of thoracic 
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vertebrae, (60,116,117) this area of reference is wide and difficult to accurately 
identify at fluoroscopy. (118) 
The air-filled left main stem bronchus serves as a convenient fluoroscopic 
landmark for this general location of bronchial artery origin. The catheter tip is 
initially directed laterally to anterolaterally when one is searching for the right 
bronchial artery or intercostobronchial trunk. A left lateral to anterolateral direction 
is used for left bronchial artery catheterization. Before embolization, a selective 
arteriogram must be performed. Bronchial arteries have characteristic branches that 
follow the course of the main stem bronchi toward the hila and can be easily 
differentiated from intercostal arteries, which have an initial cephalic course and 
then travel laterally along the undersurface of a rib. Coughing may be elicited 
during a bronchial artery injection, whereas a pure intercostal artery injection may 
be painful but will not initiate coughing. Nonionic contrast media should be used 
for all injections.  
The injection volumes and rates must be sufficient to identify any spinal artery 
branches that may exist. The spinal artery can be identified by its characteristic 
cephalic course with a hairpin bend in the midline within the spinal canal. If there 
is some doubt concerning a midline branch on an anteroposterior film, an oblique 
film should be obtained to identify whether this branch does indeed enter the spinal 
canal. Tracheal and esophageal branches also originate from the bronchial artery 
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and may appear midline on anteroposterior films but do not feature the hairpin 
loop.  When abnormal bronchial arteries are not identified, arch aortography and 
selective subclavian arteriography must be performed to search for anomalous 
bronchial arteries, nonbronchial systemic arterial supply, or both. (18,119,120)  
 
ii) ANGIOGRAPHIC FINDINGS IN HEMOPTYSIS 
The following findings are noted in cases with hemoptysis on angiography: 
a)  Hypervascularity 
b)  Bronchial artery hypertrophy more than 1.5 mm 
c)  Broncho pulmonary shunting 
d)  Dense soft tissue staining 
e)  Active extravasation of contrast 
d)  Vascular abnormalities like bronchial artery pseudoaneurysm 
(9,2,10,14,16,21,40,93,121-124) 
A recent study showed a poor correlation between bronchial arterial dilatation and 
the risk of hemorrhage. (125) and no angiographic abnormalities were found in 
11% of hemoptysis patients in another study.(2) Anomalous bronchial arteries 
represent a potential pitfall during bronchial artery embolization. Radiologists 
involved in embolotherapy for hemoptysis should therefore be alerted to the 
possible presence of anomalous bronchial arteries, especially when significant 
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bronchial artery supply to areas of abnormal pulmonary parenchyma is not 
demonstrated at a catheter search or aortography of the descending aorta. (65) 
 
iii) IDENTIFICATION OF NONBRONCHIAL SUPPLY 
On angiographic studies, systemic vessels responsible for an abnormal 
collateral blood supply to the lungs in episodes of hemoptysis appear as dilated, 
usually tortuous arteries with associated parenchymal staining by contrast material, 
systemic- to-pulmonary arterial shunting, and, rarely, contrast material 
extravasation at the points of bleeding. (3,26,61) 
More than one third have nonbronchial systemic artery contributions, 
indicating that a concerted search for these is mandatory. (2,17) Of particular 
importance is the subclavian artery and its branches (most commonly, the internal 
mammary artery) for upper-lobe bleeding and the inferior phrenic artery for lower-
lobe bleeding. (2,13,14,16-18,120) However, numerous additional vessels may 
give rise to a nonbronchial systemic arterial supply to the lung, such as the 
branches of the axillary arteries, the intercostals arteries, or the hepatic and gastric 
arteries. (9, 19, 126,127) 
Subclavian artery angiography studies have demonstrated that the internal 
mammary artery, lateral thoracic artery and subscapular artery were the main 
hemorrhagic arteries. Corresponding subclavian artery angiography should be 
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performed after the hemorrhagic branches of descending aorta artery have been 
embolized for hemoptysis due to pulmonary tuberculosis, especially in cases with 
failed embolization, or complicated with severe pulmonary fibrosis, cavity 
formation, aspergilloma, pleural thickening, or postoperative thorax. The 
hemorrhagic arteries shown by subclavian artery angiography must be embolized. 
(127) If lower-lobe disease is present, an abdominal aortogram and examination of 
the inferior phrenic arteries should also be performed. If no systemic (bronchial or 
nonbronchial) arterial supply is identified, selective pulmonary arteriography 
should be performed in an attempt to identify a pulmonary arterial source such as a 
pseudoaneurysm or arteriovenous fistula. (15,16,111,124,128-130) 
 
iv) IDENTIFICATION OF SPINAL SUPPLY 
Anterior medullary arteries have a characteristic “hairpin” configuration at 
angiography. Radicular arteries are often visualized during BAE. Unintentional 
embolization of radicular arteries does not cause clinical problems like spinal cord 
ischemia. It has been stated that the presence of radicular arteries is not considered 
to be a contraindication for BAE. (3,66,117) 
If there is some doubt concerning a midline branch on an anteroposterior 
film, an oblique film should be obtained to identify whether this branch does 
indeed enter the spinal canal. Tracheal and esophageal branches also originate 
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from the bronchial artery and may appear midline on anteroposterior films but do 
not feature the hairpin loop.  Occasionally, a spinal artery branch will only be 
identified after partial distal embolization when the resistance of that vascular bed 
is elevated and smaller proximal branches are better opacified. (66) Some authors 
have advised the use of an intraarterial barbiturate as a provocative test in 
searching for an occult spinal artery contribution before bronchial artery 
embolization. (131,132) Transverse myelitis associated with BAE has more 
commonly been associated with the use of ionic contrast media. (133,134) 
 
F) EVALUATION OF RECURRENT HEMOPTYSIS 
Patients with mycetoma have been reported with high recurrence after initial 
embolization. (39) Recurrent nonmassive hemoptysis is also common in patients 
with cystic fibrosis, where these recurrent bleeds are debilitating and preclude 
routine postural drainage of other lung regions. (66,135,136)  
In cases of recurrence in spite of accurate embolization of pathological arteries, the 
presence of bronchial arteries of anomalous origin should be considered. 
Embolization is more difficult in these cases and there is an increased risk of 
complications. (62) Selective pulmonary angiography is also performed in cavitary 
tuberculous patients with severe hemoptysis uncontrolled by previous bronchial 
and systemic arterial embolization which might reveal Rasmussen aneurysms.  
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These are effectively treated by steel coil occlusion. (46) The most significant 
factor affecting recurrence was whether the inflammation caused by the underlying 
disease was medically well controlled. (137)  
 
5) COMPARISON OF CT AND CONVENTIONAL ANGIOGRAPHY 
Multi–detector row helical CT angiography has been shown to provide more 
precise depiction of bronchial and nonbronchial systemic arteries than does 
conventional angiography(21) and can help in the planning of a focused and 
efficient nonbronchial systemic artery embolization, as was recently reported with 
single– detector row CT. (20) Bronchial arteries of anomalous origin are easily 
overlooked during bronchial artery embolization, even when complemented with 
arch aortography but are well depicted with extended thoracic CT angiography that 
includes the base of the neck and the upper abdomen. (63) Nonbronchial systemic 
artery embolization can be done  at first intention because CT angiography can 
depict the type of nonbronchial supply,its origin and course accurately. (21) If CT 
angiography is not performed and the bronchial arteries are normal or in case of 
recurrence after successful bronchial artery embolization, subclavian angiography 
or abdominal aortography (for inferior phrenic arteries) must be performed in cases 
with upper lobe or lower lobe disease respectively. (17,127) If there is no 
nonbronchial systemic vessel, then pulmonary angiography must be done to detect 
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a possible Rasmussen aneurysm. (46) A recent study has shown that MDCT and 
conventional angiography have almost equal capability in depicting the ostia of 
bronchial arteries. 3D images of MDCT aids in the depiction of ectopic origin of 
bronchial arteries, enabling the interventional radiologists to perform successful 
embolization after direct catheterization of the ectopic vessel. (21) 
 
6) EMBOLOTHERAPY FOR HEMOPTYSIS CONTROL 
Bronchial artery embolization is a well-established, worthwhile, palliative 
control of severe as well as recurrent mild hemoptysis secondary to inflammatory 
disease. Indications for embolization have expanded to include not only severe and 
massive bouts of hemoptysis but also mild to chronic and intermittent episodes of 
hemoptysis as well. The procedure should be performed promptly when indicated, 
and, when good embolization techniques are used, complications are infrequent. 
(23,26,117,135,138) 
i) TECHNIQUE 
The goal of the embolization procedure varies, depending on whether the 
bleeding site has been located with some degree of reliability and whether there 
have been previous embolization procedures. If the site of hemorrhage is known, 
attention can be confined to embolization of bronchial arteries and collaterals 
supplying that area. (85)  Distal embolization should be performed whenever 
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possible. If permanent proximal occlusion alone is performed, distal collaterals 
will invariably develop, and future access to the main bronchial artery may be lost. 
The average number of arteries embolized per patient was 2.5. (9) In cases of 
hemorrhage when the cause is not easily identified, or in cases of recurrence in 
spite of accurate embolization of pathological arteries, the presence of bronchial 
arteries of anomalous origin should be considered. Embolization is more difficult 
in these cases and there is an increased risk of complications. (62) The higher risk 
of subsequent complications is due to their frequent proximity to the vertebral and 
carotid arteries and to the difficulty in achieving stable selective catheterization of 
these arteries. (21,62,117) 
Occasionally, a spinal artery branch will only be identified after partial distal 
embolization when the resistance of that vascular bed is elevated and smaller 
proximal branches are better opacified. (66) Embolization of a bronchial artery 
with a documented spinal artery contribution is controversial and depends on 
operator experience and the risk-benefit ratio of bronchial artery embolization (i.e., 
the clinical status of the patient)     Clearly a catheter position distal to the spinal 
artery origin is preferential and is often achievable with modern coaxial systems.  
Anterior medullary arteries have a characteristic “hairpin” configuration at 
angiography. Radicular arteries are often visualized during BAE. In our 
experience, unintentional embolization of radicular arteries does not cause clinical 
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problems like spinal cord ischemia. It has been stated that the presence of radicular 
arteries is not considered to be a contraindication for BAE. (3,117,139) 
Superselective embolization is safer and more effective way to control hemoptysis 
than the ordinary (nonsuperselective) method. It lowers the incidence of spinal 
cord injury. (140) 
 
ii) EMBOLIZING MATERIALS 
The most commonly used embolic materials for bronchial artery 
embolization include Gelfoam and polyvinyl alcohol (PVA) particles. 
(2,14,23,122,123,136,138,139)   Gelfoam (gelatin sponge) is the most commonly 
used material. It is a readily available, slowly resorbable material that can be used 
as individual pledgets, torpedoes, or part of a slurry. For initial distal occlusion, 
0.5- to 2.0-mm cubes can be used followed by 3- to 4-mm pledgets or torpedoes 
for more proximal occlusion. Gelfoam pledgets are mixed with dilute contrast 
within a 1- or 3-ml syringe. Since the Gelfoam pledgets float within the contrast 
saline solution, the tip of the syringe should be pointed upward. A theoretical 
disadvantage of Gelfoam particles is that their resorption may lead to more rapid 
recanalization and recurrent bleeding.  (141) 
Enormous bronchial arteries with high flow and large systemic-to-
pulmonary shunts sometimes encountered in cystic fibrosis may require the use of 
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coil embolization for safe and adequate occlusion.  Coils should be 15 to 25 
percent larger than the vessel diameter to avoid retrograde dislodgment, and the 
catheter should be well seated. (30,142-144)   Coil embolization therapy is also 
used in the embolization of bronchial artery pseudoaneurysms. (43)  
 
iii) NONBRONCHIAL SYSTEMIC ARTERY EMBOLIZATION 
Persistent hemoptysis after a technically successful bronchial artery 
embolization constituted an indication for embolization of nonbronchial systemic 
arteries, which is always considered at second intention because of (a) the potential 
neurologic iatrogenic risks when embolizing these vessels, especially collaterals of 
the subclavian artery (owing to the proximity of the vertebral artery) and the 
intercostal and inferior phrenic arteries (owing to the likelihood of a major spinal 
cord supply from these branches), and (b) the lack of a constant relationship 
between arterial hypervascularity and bronchial bleeding. On the contrary, 
embolization of nonbronchial systemic arteries is systematically considered at first 
intention for the management of hemoptysis of congenital origin. (21) Massive 
hemoptysis can be effectively controlled by the embolization of intercostal trunks, 
if these are shown to supply the bleeding sites in patients who are poor candidates 
for surgery. If any important branch to the spinal cord is visualized on preliminary 
angiography, this procedure can be employed without complication if the 
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intercostal vessel is embolized distal to the origin of the anastomotic branch to the 
spinal cord.  (13) 
The internal mammary artery contributes to the perfusion of lesions 
responsible for hemoptysis when the basic lesion involves the pulmonary 
parenchyma adjacent to the anterior pleural surface. Initial distal occlusion of the 
internal mammary artery may improve the efficacy of embolization of this artery 
for hemoptysis. (69) Corresponding subclavian artery angiography should be 
performed after the hemorrhagic branches of descending aorta artery have been 
embolized for hemoptysis due to pulmonary tuberculosis, especially in cases with 
failed embolization, or complicated with severe pulmonary fibrosis, cavity 
formation, aspergilloma, pleural thickening, or postoperative thorax. The 
hemorrhagic arteries shown by subclavian artery angiography must be embolized. 
(127) 
 
iv) COMPLICATIONS OF BAE 
Complications of BAE procedures include subintimal dissection of the aorta 
leading to mediastinal hematoma, referred pain to the ipsilateral orbit , transient 
dysphagia ,  diaphragmatic paralysis , bronchoesophageal fistulas , transient 
thoracic pain, transient leg pain, bronchial arterial perforation by a guidewire, 
reflux of embolic material into the aorta and spinal cord complications. The latter 
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complication may be a Brown-Se´quard syndrome, paraparesis or complete 
paraplegia. (9,13,19,25,144) Transverse myelitis associated with BAE was 
common in the past and was associated with the use of ionic contrast media. Hence 
nonionic contrast agents should be routinely used. (133,134) Spinal infarction can 
occur with nonsuperselective embolization. (140) To lower the incidence of spinal 
cord injury, monitoring with somatosensory-evoked potentials has been proposed 
by some authors. (114) A recent study has shown that with preembolization MDCT 
angiography, no complications were encountered after the embolization of 
bronchial and nonbronchial systemic arteries. (21) 
 
v)  BAE EFFICACY 
BAE has excellent immediate control of hemoptysis (77-100%)  
(16,23,26,93,117,138) The immediate effect was unfavorable in cases where feeder 
vessels were overlooked or the embolization of the intercostal arteries was 
insufficient. (137) Tamura et al. demonstrated long-term hemostasis in 70 percent 
of patients without documented pleural thickening, whereas this was achieved in 
only 29 percent of patients with significant pleural thickening. (94) BAE can also 
be done in patients with primary lung cancer despite the fact the vascular changes 
are subtle on angiography. (145) 
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While arterial embolization as initial treatment of hemoptysis is a highly 
useful procedure, this is a palliative procedure and potential for recurrence of 
hemoptysis exists as the lesion that has initially caused hemoptysis is not cured by 
the embolization. (39) Etiologic therapy aimed at removing the infection leading to 
chronic inflammation is the cure for tuberculosis and hemoptysis. (146) Surgery 
remains the procedure of choice in the treatment of massive hemoptysis caused by 
specific conditions, such as hydatid cyst, thoracic vascular injury, bronchial 
adenoma, and aspergilloma that is resistant to other therapies. (12) Even in surgical 
candidates, BAE is effective in preparing the patient for elective rather than high-
risk emergency surgery.(7) Embolization of bronchial and systemic arteries is an 
effective method for treating acute severe hemoptysis from intracavitary 
aspergillomas, allowing the patient time to recover for definitive surgical 
management. (147) 
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MATERIALS AND METHODS 
 
PATIENT POPULATION 
28 consecutive patients (25 men, 3 women; mean age, 40.2 years; range, 18–
65 years) referred to our institution in a six-month period for endovascular 
treatment of hemoptysis underwent multi–detector row helical CT angiography as 
part of pretherapeutic evaluation.   
Prior to the introduction of multi–detector row helical CT technology, each 
patient referred for the management of bronchial bleeding at our institution 
underwent a nonenhanced CT examination of the thorax. Since multi–detector row 
helical CT offers the possibility of providing additional information regarding the 
source of bronchial bleeding, the inclusion of a CT angiography study was 
approved by our institutional review board in the clinical context of hemoptysis.  
Care was taken to avoid administration of contrast material if 
contraindications existed, such as renal insufficiency (creatinine level greater than 
150 mmol/L), iodine intolerance, or use of biguanide in cases of diabetes mellitus. 
The present study is a retrospective review of the imaging studies performed in 
these patients. The average quantity of hemoptysis per episode prior to 
embolization was about 160 ml (range, 5 - 1000ml). The number of hemoptysis 
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episodes ranged from one to more than hundred and the duration of hemoptysis 
ranged from one day to 12 years. 
History of ATT intake for tuberculosis was present in 23 patients. One 
patient was sputum positive for tubberculosis during evaluation and five patients 
were diabetic.  Mean hemoglobin of patients was 10.7 grams/100ml (range, 4.6 – 
17 grams/100ml).  All patients had either clinical or imaging features of 
Tuberculosis. 
The mean quantity of hemoptysis in last 3 days prior to admission in patients 
with cavity was 422ml whereas it was 248 ml in patients without cavity.  The mean 
quantity of hemoptysis in last 3 days prior to admission in patients with 
aspergilloma was 451 ml, whereas it was 324 ml in patients without aspergilloma. 
 
MDCT ANGIOGRAPHY 
CT angiography was performed with a 64–detector row scanner (Brilliance 
64; Philips, Holland) (Figure 4) for all patients (120 kV, 60–100 mAs, rotation 
time of 0.5 second, 0.75-mm collimation, pitch of 1.5). The respective mean height 
of the volume scanned and the mean duration of data acquisition were 350 mm and 
10  seconds.  (Figure 5) 
Patients received 80–100 mL of contrast material (iohexol, Omnipaque 350; 
Amersham Health, Carrigtohill, Ireland) with 350 mg of iodine per milliliter and 
39 
 
an injection rate of 4 mL/sec. The automatic bolus triggering software program 
was systematically applied, with a circular region of interest positioned at the level 
of the ascending aorta and a threshold for triggering data acquisition preset at 100 
HU after an initial scanogram. (Figures 6,7) 
From each data set, three series of images were systematically reconstructed 
as follows: contiguous 1-mm-thick transverse CT scans viewed at mediastinal and 
lung window settings, oblique coronal and sagittal maximum intensity projections 
(MIPs), and three-dimensional volume- rendered images of the thoracic vascular 
structures. 
 
CT Analysis 
CT analysis is done in the following steps in cases of life threatening hemoptysis. 
 STEP 1: Study Lung parenchyma for disease process 
 STEP 2: Measure Pleural thickening 
 STEP 3: Determine the Bleeding Bronchial arteries 
 STEP 4: Localise the Origin of the Bronchial Artery in 3 planes 
 STEP 5: Map proximal course of Bronchial Artery 
 STEP 6: Search and localise Nonbronchial Systemic Arteries and pulmonary 
vessels causing hemoptysis  
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STEP 1: Study Lung parenchyma for disease process 
The lung parenchyma is studied in detail, mainly looking out for cavities, 
bronchiectasis and any mass lesion communicating with bronchi.  Since most of 
the patients were having clinical or radiological tuberculosis, the main foci was on 
Cavities and associated Bronchiectasis. Aspergilloma within old tuberculous cavity 
is an important cause for recurrent hemoptysis and hence was specially searched 
for, especially in diabetic patients. (Figure 8)  Air space disease indicates active 
disease and has to be noted.  The analysis of lung parenchyma will help to 
lateralize the disease process when lesions are present in both lungs on chest 
radiography.  It will also locate the probable lesion causing the bleed. 
 
STEP 2: Measure Pleural thickening 
Pleural thickening has to be measured on both sides between the visceral 
pleura – lung interface and the parietal pleura – rib interface.  Apical predominance 
of lesions is noted in tuberculosis, and hence apical pleural thickening is seen in 
many patients. (Figure 9)  Thickening of the apical pleura more than 3mm was 
associated with non bronchial systemic supply, especially from internal mammary 
artery leading to recurrent hemoptysis.  Also, basal pleural thickening is doubted to 
be associated with supply from inferior phrenic artery. 
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STEP 3: Determine the Bleeding Bronchial arteries 
Signs of bleeding vessel on MDCT 
 Hypertrophied vessel – diameter more than 1.5 mm (Figure 10) 
 Tortuosity of the vessel (Figure 11, 12) 
 Parenchymal staining 
 Broncho pulmonary shunt (Figure 13) 
 Active leak from vessel 
 
STEP 4: Localise the Origin of Bronchial Artery in 3 planes 
Next, the origin of the bleeding bronchial artery has to be localized in three 
planes.  (Figure 14) In the Z- axis (Craniocaudal), the carina, the vertebral body, or 
the left main bronchus can be used as a reference.  (Figure 15,16) However, during 
angiography, it is seen that the left main bronchus is easily recognized and can be 
consistently used as a reference level.  In the X and Y axes (axial), the origin of the 
bronchial artery is plotted with reference to a clock face. (Figure 17)  All bronchial 
arteries and the bleeding intercostals arteries can be localized in the axial plane by 
this method to assist the interventional radiologist in entering the bleeding vessel. 
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STEP 5: Map proximal course of Bronchial Artery 
The proximal course of the pathologic bronchial or intercostobronchial artery is 
then mapped with help of Maximum Intensity Projection (MIP), Curved MIP or 
Shaded Surface Display (SSD) techniques (Figures 18 – 20) .  Since 
intercostobronchial artery origin of right bronchial artery is common, it is 
important to note the division of the intercostals and bronchial trunks to avoid 
intercostals artery embolisation which can give rise to severe pain and other 
complications. It is important to note the level of origin of any prominent radicular 
artery or an ectopic artery of adamkiewicz from the bronchial or 
intercostobronchial artery.  Rarely, coronary or phrenic branches can arise from the 
bleeding vessel and the origin of these vessels must also be mapped in order to 
avoid them by super selective embolisation. 
 
STEP 6: Search and localise Nonbronchial Systemic Arteries and pulmonary 
vessels causing hemoptysis  
Various nonbronchial systemic arteries have been described as potential 
causes for primary and recurrent hemoptysis and it is necessary to identify these 
vessels after identification of the bronchial arteries.  These vessels assume 
importance especially when the bronchial arteries are of normal size and when 
there is marked pleural thickening.  When there is no hypertrophied nonbronchial 
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systemic vessel, the pulmonary vessels are finally analysed, since they can rarely 
be a source of life threatening hemoptysis.  Rasmussen aneurysms from the 
pulmonary vasculature can be seen in the wall of tuberculous cavities and can 
bleed profusely. 
 
CONVENTIONAL ANGIOGRAPHY 
Angiography was performed after MDCT angiography.  The mean time 
interval between admission and MDCT was 7 days (range, 1-28 days).  The mean 
time interval between MDCT and catheter angioembolization was 3 days (range, 1-
6days) Angiography was was done with a 500mA Shimadzu(Japan)  Fluoroscopy 
machine.  (Figure 21) All patients had a right transfemoral approach with arterial 
puncture by modified Seldinger’s technique.  6 F Sheath was used for all cases and 
a 5F or 6 F Cobra Catheter was used to hook the bronchial arteries.  Nonionic 
iodinated contrast material (Iohexol) was used and on an average, about 150 ml of 
contrast was used per patient.  The mean duration of angioembolization (from 
sheath insertion to sheath withdrawl) was 43 minutes. 
Flush aortography was done in all patients prior to a search for the bronchial 
arteries.  Since it is a life saving procedure, the information regarding the bronchial 
artery size and ostial location was utilized during the search for pathological 
bronchial arteries.  Initially, the bronchial artery on the side with the major 
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parenchymal disease process was searched for.  Search for multiple bronchial 
arteries was then made.   
The contralateral bronchial arteries were also checked in every case.  Then, a 
search for nonbronchial systemic arteries was done whenvever there was a 
significant pleural thickening.  Not all nonbronchial systemic arteries detected at 
MDCT was searched by conventional angiography, since it was a life saving 
procedure and the aim was to embolize the pathological bronchial artery first and 
clinically stabilize the patient. The number of bronchial arteries on each side and 
their ostial position with respect to vertebral body level was noted. 
The depiction of intra and extra pulmonary course of bronchial arteries was 
also noted.  The type of nonbronchial artery and its size and level of origin was 
also noted.  A search was also made to detect any pseudoaneurysm of bronchial 
artery.  Finally, the images were analysed for any prominent spinal medullary or 
radicular artery arising from the bronchial or nonbronchial systemic artery 
supplying the diseased lung parenchyma. 
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RESULTS 
 
A)  MDCT 
i)  ASSESSMENT OF LUNG PARENCHYMA AND PLEURA 
Disease process capable of producing hemoptysis noted in CT – Maximum 
Intensity Projection in all 28 cases. It was lateralised to one side in 17 cases. (Right 
– 7, Left – 10) It was bilateral (Not Localised to one side) in 11 cases. Cavity was 
present in 18 cases out of the total 28 cases ( 64.3%).  It was present only in Right 
Side in 7 cases and only in Left side in 6 cases. Cavity present bilaterally in 5 
cases. Bronchiectasis was noted in 16 out of 28 cases (57.1%). Cavity with 
Bronchiectasis was present in 8 out of 28 cases (28.6%). Aspergilloma was present 
in 8 out of 28 cases ( 28.6%).  Diabetes was present in 5 patients.  Diabetes with 
Aspergilloma was noted in 2 patients 
The mean right pleural thickness was 3.3mm. (Min- 0mm, Max - 15.8mm). 
12 Patients had Right Pleural thickening more than 3mm. In the 12 patients with 
right non bronchial systemic supply, the mean right pleural thickness was 5.8mm.  
(Min-2.1mm, Max - 15.8mm).   In the 16 patients without right non bronchial 
systemic supply, the mean Right Pleural thickness was 1.35mm. (Min - 0 mm, Max 
- 7.7mm).  In the12 patients with Rt Pleural thickness more than  3mm, Right Non 
Bronchial supply was noted in 9 patients ( 75%). 
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The mean left pleural thickness was 4.12mm. (Min- 0mm, Max – 12.9mm). 
16 Patients had left Pleural thickening more than 3mm. In the 16 patients with left 
non bronchial systemic supply, the mean left pleural thickness was 6.9 mm.  (Min-
0 mm, Max – 12.9 mm).   In the 12 patients without left non bronchial systemic 
supply, the mean left Pleural thickness was 1.4 mm. (Min - 0 mm, Max – 6 mm).  
In the16 patients with Lt Pleural thickness more than  3mm, Left Non Bronchial 
supply was noted in 13 patients ( 81.25%). 
RT PL THICK >3MM * RT NON BRONCHIAL SYSTEMIC Crosstabulation
9 3 12
32.1% 10.7% 42.9%
3 13 16
10.7% 46.4% 57.1%
12 16 28
42.9% 57.1% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
YES
NO
RT PL THICK
>3MM
Total
PRESENT ABSENT
RT NON BRONCHIAL
SYSTEMIC
Total
 
Sensitivity =75   % ; Specificity =   81.25 % 
Positive Predicitve Value =  75  % ; Negative Predicitve Value =  81.25 % 
Chi-Square Tests
8.859b 1 .003
6.711 1 .010
9.304 1 .002
.006 .004
8.543 1 .003
28
Pearson Chi-Square
Continuity Correction a
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
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LT PL THICK >3MM * LT NON BRONCHIAL SYSTEMIC Crosstabulation
13 3 16
46.4% 10.7% 57.1%
1 11 12
3.6% 39.3% 42.9%
14 14 28
50.0% 50.0% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
YES
NO
LT PL THICK
>3MM
Total
PRESENT ABSENT
LT NON BRONCHIAL
SYSTEMIC
Total
 
Sensitivity = 92.86  % ; Specificity = 78.57   % 
Positive Predicitve Value =  81.25  % ; Negative Predicitve Value =  91.67 % 
Chi-Square Tests
14.583b 1 .000
11.813 1 .001
16.490 1 .000
.000 .000
14.063 1 .000
28
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
 
ii)  RIGHT BRONCHIAL ARTERIES 
Right Bronchial Arteries were noted in 28 out of 28 cases(100%).  Totally 
43 right bronchial arteries were visualized. 17 cases had single bronchial artery, 7 
cases had double bronchial artery and 4 cases had triple bronchial artery supply.  
On an average, 1.54 bronchial arteries were noted per case. 
Intercostobronchial origin of right bronchial artery was noted in 25 out of 28 cases 
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(89.3%)  The mean diameter of Right bronchial artery was 1.635mm.  
Hypertrophied Right Bronchial artery (more than 1.5mm) was noted in 17 out of 
28 cases ( 60.7%). 20 out of the 43 right bronchial arteries (46.5%) were found to 
be hypertrophied.  The right bronchial arteries were found to have their origin at 
D4 level in 2 arteries, D5 level in 26 arteries, D6 level in 13 arteries and D7 level 
in 2 arteries.  (Figure 22) The orthotopic origin of Right bronchial artery (D5 and 
D6level) was noted in 39 out of 43 arteries (91%). (Figure 23)  
Ostia(clock position) of right bronchial artery was at 9’oclock in 25 arteries, 
10’o clock in 4 arteries, 11’o clock in 3 arteries, 12’o clock in 9 arteies and at 1’o 
clock in 2 arteries. 9 and 10 o clock Ostial position of right bronchial artery was 
noted in 29 out of 43 Arteries (67.3%). (Figure 24) 
The right bronchial arteries excluding the common trunk of origin were 
found to have their origin at D4 level in 1 artery, D5 level in 19 arteries, D6 level 
in 7 arteries and D7 level in 1 artery. Orthotopic origin (D5 and D6 origin ) of 
Right bronchial arteries excluding Common trunk of origin was noted in 26 out of 
28 Arteries (92.9%). Ostia(clock position) of right bronchial artery excluding 
common trunk of origin was at 9’oclock in 25 arteries, 10’o clock in 2 arteries, and 
at 1’o clock in 1 arteries. 9 and 10 o clock Ostial position of right bronchial artery 
excluding common trunk was noted in 27 out of 28 Arteries (96.4%). (Figure 
25,26) 
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Direct origin of Right Bronchial arteries (as opposed to intercostobronchial 
origin) were noted in 3 arteries. All 3 arteries arose at D5 level.  They had their 
ostial location at 9’oclock, 10’o clock and 1’0 o clock positon. 9 and 10 o clock 
Ostial position of Direct right bronchial arteries was 2 out of 3 Arteries (66.7%) 
MDCT showed signs of hemoptysis producing disease in right lung alone in 7 out 
of 28 cases (25%) 
  
CT >1.5mm 
RBA 
CT <1.5mm 
RBA 
CT Positive Only Right Lung Disease 6 1 
CT Negative Only Right Lung Disease 11 10 
Sensitivity =   35.29% ; Specificity=  90.91 % 
Positive Predicitve Value = 85.71   % ; Negative Predicitve Value =  47.6  % 
Analysis: 'N-1' Chi squared = 2.36, P = 0.12 
MDCT signs of Hemoptysis Producing disease in right lung and bilateral disease 
was noted in 18 out of 28 cases (64.3%) 
  
CT >1.5mm 
RBA 
CT <1.5mm 
RBA 
CT Positive Probable Right Lung Disease 15 3 
CT Negative Probable Right Lung Disease 2 8 
Sensitivity =   88.24% ; Specificity=   72.73% 
Positive Predicitve Value =  83.33  % ; Negative Predicitve Value =  80  % 
Analysis: 'N-1' Chi squared = 10.42, P = 0.001 
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In Cases with Probable Right Lung disease by CT 
  CT Significant 
RBA Present  
CT Significant RBA 
Absent  
Catheter Angio RBA Present 14 2 
Catheter Angio RBA Absent 1 1 
Sensitivity =   93.33% ; Specificity=   33.33% 
Positive Predicitve Value =  87.5  % ; Negative Predicitve Value = 50   % 
Analysis:  Fishers Exact test 1-tail P = 0.314 
No. of Right Bronchial Arteries Detected Per Patient on MDCT  
17 60.7 60.7 60.7
7 25.0 25.0 85.7
4 14.3 14.3 100.0
28 100.0 100.0
1
2
3
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
iii)  RIGHT INTERCOSTOBRONCHIAL ARTERY 
Right Intercostobronchial artery was visualised in 25 out of 28 cases ( 
89.3%) and in 25 out of 43 Arteries ( 58.1%) All Right Intercostobronchial arteries 
were single vessels. The Mean Diameter of Intercostobronchial artery was 2.3mm. 
The Origin of Right Intercostobronchial (N=25) was at D4level in 1 case, D5 level 
in 16 cases, D6 level in 7 cases and D7 level in 1 case. D5 and D6 origin of Right 
Intercostobronchial was noted in 23 out of 25 Arteries or cases ( 92%). The Ostial 
position of Right Intercostobronchial(N=25) was noted at 9’oclock in 21 cases, 
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10’o clock in 3 cases and 11’o clock in 1 case. 9 and 10 o clock Ostial position of 
Right Intercostobronchial was noted in 24 out of 25 cases ( 96%) (Figure 27) 
 
iv)  LEFT BRONCHIAL ARTERIES 
Left Bronchial Arteries were noted in 28 out of 28 cases (100%). (Figure 28)  
Totally, 46 left bronchial arteries were visualized in 28 cases. A maximum of 2 
bronchial arteries were noted per patient.  Single left bronchial artery was noted in 
10 cases and double left bronchial supply in 18 cases.  There was no case with 
triple left bronchial supply.  On an average, 1.64 bronchial arteries were noted per 
case. Intercostobronchial origin of left bronchial artery was not noted in any case.  
The mean Diameter of left bronchial artery was found to be 1.478 mm.  
Hypertrophy of left bronchial artery (more than 1.5mm diameter) was noted in 19 
out of 28 cases ( 67.9%) or 20 out of 46 Arteries (43.5%) 
The origin of any left bronchial artery (N=46): was noted at D4 level in 3 
arteries, D5 level in 20 arteries=3, D6 level in 19 arteries and D7 level in 4 arteries. 
D5 and D6 origin of any left bronchial artery was noted in 39 out of 46 Arteries ( 
84.8%) Ostial position of any Left bronchial artery was noted at 9’o clock in 6 
arteries, 10’o clock in 1 artery, 11’0 clock in 9 arteries, 12’o clock in 20 arteries, 
1’o clock in 10 arteries and 2’o clock position in 1 artery. 11 to 1 o clock Ostial 
position of any left bronchial artery was noted in 39 out of 46 Arteries (84.8%).   
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The origin of  left bronchial artery  excluding common trunks (N=31) was 
noted at D4 level in 2 arteries, D5 level in 12 arteries, D6 level in 14 arteries and  
D7level in 3 arteries. D5 and D6 origin of LBA Excluding Common Trunks = 26 
out of 31 Arteries = 83.9%  The ostial position of left bronchial artery excluding 
common trunks(N=31) was at  9’o clock position in 2 arteries, 10’o clock position 
in 1 artery, 11’o clock position in7arteries, 12’o clock position in 12 arteries, 1’o 
clock position in 8 arteries and  2’o clock position in 1 artery. 11 to 1 o clock 
Ostial position ofleft bronchial artery excluding Common Trunks was noted in 27 
out of 31 Arteries =(87.1%) (Figure 29,30) 
MDCT showed signs of hemoptysis producing disease in left lung alone in 10 out 
of 28 cases (35.7%) 
  CT >1.5mm 
LBA 
CT <1.5mm 
LBA 
CT Positive Only Left Lung Disease 9 1 
CT Negative Only Left Lung Disease 10 8 
Sensitivity =   47.37% ;  Specificity=  88.89 %  
 Positive Predicitve Value = 90   % ; Negative Predicitve Value = 55.55   % 
Analysis: 'N-1' Chi squared = 3.37, P = 0.07 
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MDCT signs of Hemoptysis Producing disease in left lung and bilateral disease 
was noted in 21 out of 28 cases ( 75%) 
  CT >1.5mm 
LBA 
CT <1.5mm 
LBA 
CT Positive Probable Left Lung Disease 18 3 
CT Negative Probable Left Lung Disease 1 6 
Sensitivity =  94.74% ; Specificity= 66.67%  
Positive Predicitve Value =  85.71  %;  Negative Predicitve Value =   85.71 % 
Analysis: 'N-1' Chi squared = 11.84, P = 0.001 
In Cases with Probable Lt Lung disease by CT 
  CT Significant 
LBA Present 
CT Significant LBA 
Absent 
Catheter Angio LBA Present 12 1 
Catheter Angio LBA Absent 6 2 
Sensitivity =   66.67%; Specificity=    66.67% 
Positive Predicitve Value =  92.3  % ; Negative Predicitve Value =  33.33  % 
Analysis: 'N-1' Chi squared = 1.15, P = 0.3 
No. of Left Bronchial Arteries Detected Per Patient on MDCT 
10 35.7 35.7 35.7
18 64.3 64.3 100.0
28 100.0 100.0
1
2
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
54 
 
v)  COMMON TRUNK BRONCHIAL ARTERY 
Common Trunk for right and left Bronchial Artery was noted in 13 out of 28 
patients ( 46.4%). Totally 15 common trunk arteries were noted. 11 patients had 
single common trunk and 2 patients had two common trunks. Origin of Common 
trunk artery (N=15) was at D4 level in 1 artery, D5 level in 7 arteries, D6 level in 6 
arteries and D7 level in 1 artery. D5 and D6 origin of Common trunk artery was 
noted in 13 out of 15 Arteries (86.7%).  The ostial position of common trunk artery 
(N=15) was at  9’o clock position in 3 arteries, 11’o clock position in2 arteries, 
12’o clock position in 8 arteries and 1’o clock position in 2 arteries.  9 and 10 o 
clock Ostial position of Common trunk artery was noted in 3 out of 15 cases 
(20%). 11 to 1 o clock Ostial position of Common trunk artery 12 out of 15 
cases(80%) 
 
vi)  NONBRONCHIAL SYSTEMIC ARTERIES 
Nonbronchial Systemic supply was noted on the right side in 12 out of 28 
patients (42.9%).  Totally, 23 Non Bronchial Systemic Arteries were noted on 
Right side. Nonbronchial Systemic supply was noted on the left side in 14 out of 
28 patients (50%).  Totally, 41 Non Bronchial Systemic Arteries were noted on left 
side.  (Figures 33-39) The mean diameter of right internal mammary artery in all 
cases (N=28) was noted to be 2.64 mm. (Min = 1.8mm.  Max = 4.9mm) 
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Nonbronchial Systemic supply from right internal mammary artery was noted in 6 
cases out of 28 (21.4%).   Mean diameter of right internal mammary artery was 
noted in these cases to be 3.77mm. (Min = 3mm.  Max = 4.9mm) No Nonbronchial 
Systemic supply from right internal mammary artery was noted in in 22 out of 28 
cases (78.6 diameter of right internal mammary artery was noted in these cases to 
be 2.33mm.  (Min = 1.8mm.  Max = 2.9mm) 
The mean diameter of left internal mammary artery in all cases (N=28) was 
noted to be 2.81 mm. (Min = 1.5mm.  Max = 4.7mm) Nonbronchial Systemic 
supply from left internal mammary artery was noted in 12 cases out of 28 ( 42.8%).   
Mean diameter of left internal mammary artery was noted in these cases to be 
3.8mm. (Min = 3.1mm.  Max = 4.7mm) No Nonbronchial Systemic supply from 
left internal mammary artery was noted in in 16 out of 28 cases (57.1% diameter of 
left internal mammary artery was noted in these cases to be 2.07mm.  (Min = 
1.5mm.  Max = 2.8mm) 
Between D4 and D7 level, the right intercostal arteries in all 28 patients 
were noted  to originate from the descending thoracic aorta between 9 and 10’o 
clock position (100%). (Figure 31) Between D4 and D7 level, the left intercostal 
arteries in all 28 patients were noted to originate from the descending thoracic 
aorta between 6 and 7’o clock position (100%). (Figure 31) 
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No. of Non Bronchial Systemic Arteries Detected Per Patient on Right Side  
16 57.1 57.1 57.1
6 21.4 21.4 78.6
3 10.7 10.7 89.3
2 7.1 7.1 96.4
1 3.6 3.6 100.0
28 100.0 100.0
0
1
2
3
5
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
ARTERY NO PERCENTAGE 
RIMA 6 26.10% 
Rt Intercostal 8 34.80% 
Rt Thyrocervical Trunk 2 8.70% 
Rt Infr Phrenic 2 8.70% 
Rt SCA 1 4.30% 
Rt Costocervical Trunk 2 8.70% 
Rt Acromiothoracic artery 1 4.30% 
Rt Pericardiophrenic artery 1 4.30% 
 
No. of Non Bronchial Systemic Arteries Detected Per Patient on Left Side   
14 50.0 50.0 50.0
3 10.7 10.7 60.7
1 3.6 3.6 64.3
1 3.6 3.6 67.9
2 7.1 7.1 75.0
2 7.1 7.1 82.1
3 10.7 10.7 92.9
1 3.6 3.6 96.4
1 3.6 3.6 100.0
28 100.0 100.0
0
1
2
3
4
5
6
9
12
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
57 
 
ARTERY NO PERCENTAGE
LIMA 12 29.30%
Lt Intercostal 10 24.40%
Lt Thyrocervical Trunk 2 4.90%
Lt Infr Phrenic 6 14.60%
Lt SCA 7 17.10%
Lt costocervical trunk 1 2.40%
Lt Gastric 1 2.40%
Lt Hepatic 1 2.40%
Lt Lateral Thoracic 1 2.40%
RIMA > 3MM * RIMA - PATH Crosstabulation
6 0 6
21.4% .0% 21.4%
0 22 22
.0% 78.6% 78.6%
6 22 28
21.4% 78.6% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
YES
NO
RIMA >
3MM
Total
PRESENT ABSENT
RIMA - PATH
Total
 
Chi-Square Tests
28.000b 1 .000
22.376 1 .000
29.096 1 .000
.000 .000
27.000 1 .000
28
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
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LIMA > 3MM * LIMA - PATH Crosstabulation
12 0 12
42.9% .0% 42.9%
0 16 16
.0% 57.1% 57.1%
12 16 28
42.9% 57.1% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
YES
NO
LIMA >
3MM
Total
PRESENT ABSENT
LIMA - PATH
Total
 
Sensitivity = 100%; Specificity = 100% 
Positive Predictive Value = 100 %; Negative Predictive Value = 100 % 
Chi-Square Tests
28.000b 1 .000
24.066 1 .000
38.243 1 .000
.000 .000
27.000 1 .000
28
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
 
NON BRONCHIAL 
SUPPLY PRESENT  
NON BRONCHIAL 
SUPPLY ABSENT  
INF PHR >2 MM 6 4 
INF PHR <2 MM 2 44 
Sensitivity = 75%; Specificity = 91.67% 
Positive Predictive Value = 60 %; Negative Predictive Value = 95.6 % 
Analysis: 'N-1' Chi squared = 20.41, P < 0.0001 
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FREQUENCY OF NONBRONCHIAL SYSTEMIC ARTERIES DETECTED IN THE STUDY 
 
B)  CONVENTIONAL ANGIOGRAPHY 
Successful embolization was done in 25 out of the 28 cases of life 
threatening hemoptysis. 21 Right bronchial arteries were visualised by 
conventional angiography and the intra and extrapulmonary course were clearly 
seen in all these cases. (Figure 40) Increased tortuosity of the vessel was noted in 
17 of these 21 arteries. 17 of the 21 right bronchial arteries had an 
intercostobronchial origin. 20 out of 21 right bronchial arteries were embolized 
successfully with gelfoam slurry. (Figure 41,42) Parenchymal staining was noted 
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in 17 of 21 right bronchial arteries. (Figure 43)  Broncho pulmonary shunting was 
noted in 14 out of 21 right bronchial arteries. 
Right Bronchial Arteries identified on Conventional Angiography  
9 32.1 32.1 32.1
19 67.9 67.9 100.0
28 100.0 100.0
 Vessel Not Indentified
Vessel Indentified
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
No. of Right Bronchial Arteries Detected on Angiography Per Patient 
9 32.1 32.1 32.1
17 60.7 60.7 92.9
2 7.1 7.1 100.0
28 100.0 100.0
0
1
2
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
No. of Right Bronchial Arteries Embolised Per Patient 
10 35.7 35.7 35.7
16 57.1 57.1 92.9
2 7.1 7.1 100.0
28 100.0 100.0
0
1
2
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
Non bronchial systemic supply was noted on the right side in 7 out of the 28 
patients. Out of these 7 patients, intercostal artery supply was present in all cases 
and an pateint had an internal mammary supply in addition. (Figure 44,45) 
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Right Sided Non Bronchial Systemic Arteries identified on Conventional Angiography  
21 75.0 75.0 75.0
7 25.0 25.0 100.0
28 100.0 100.0
 Vessel Not Indentified
Vessel Indentified
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
No. of Nonbronchial Systemic Arteries Deteced Per Patient on Right Side on Angiography 
21 75.0 75.0 75.0
6 21.4 21.4 96.4
1 3.6 3.6 100.0
28 100.0 100.0
0
1
2
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
17 Left bronchial arteries were visualised by conventional angiography and 
the intra and extrapulmonary course were clearly seen in all these cases. (Figure 
46)  All the left bronchial arteries were direct branches from the descending 
thoracic aorta. 15 out of the 17 left bronchial arteries were embolized successfully 
with gelfoam slurry. Parenchymal staining was noted in all of the 15 left bronchial 
arteries. Broncho pulmonary shunting was noted in 11 out of the 15 left bronchial 
arteries.  (Figure 47) 
Left Bronchial Arteries identified on Conventional Angiography  
15 53.6 53.6 53.6
13 46.4 46.4 100.0
28 100.0 100.0
 Vessel Not Indentified
Vessel Indentified
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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No. of Left Bronchial Arteries Detected on Angiography Per Patient 
15 53.6 53.6 53.6
9 32.1 32.1 85.7
4 14.3 14.3 100.0
28 100.0 100.0
0
1
2
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
No. of Left Bronchial Arteries Embolised Per Patient 
16 57.1 57.1 57.1
9 32.1 32.1 89.3
3 10.7 10.7 100.0
28 100.0 100.0
0
1
2
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
Non bronchial systemic supply was noted on the left side in 8 out of the 28 
patients. Left intercostal arteires, left subclavian artery branch, left inferior phrenic 
artery were the nonbronchial systemic arteries detected on the left side, with the 
left intercostals being the most common, noted in 6 out of the 8 patients with left 
nonbronchial systemic artery supply. (Figures 48,49) 
Left Sided Non Bronchial Systemic Arteries identified on Conventional 
Angiography 
20 71.4 71.4 71.4
8 28.6 28.6 100.0
28 100.0 100.0
 Vessel Not Indentified
Vessel Indentified
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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No. of Nonbronchial Systemic Arteries Deteced Per Patient on Left Side on Angiography 
20 71.4 71.4 71.4
7 25.0 25.0 96.4
1 3.6 3.6 100.0
28 100.0 100.0
0
1
2
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
Common trunk of origin was noted in 4 out of the 28 patients. No prominent 
radicular or medullary artery was identified.  No bronchial artery pseudoaneurysm 
was identified. 
C)  COMPARISON OF MDCT AND CONVENTIONAL ANGIOGRAPHY 
 
ANGIOGRAPHICALLY DETECTED * MDCT DETECTED  
RIGHT BRONCHIAL ARTERIES - CROSS TABULATION 
9 9
32.1% 32.1%
19 19
67.9% 67.9%
28 28
100.0% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
 Vessel Not Indentifie
Vessel Indentified
NO. OF RT BRONCHIA
ARTERIES- ANG
Total
Vessel
Indentified
NO. OF RT
BRONCHIAL
ARTERY- CT
Total
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ANGIOGRAPHICALLY DETECTED * MDCT DETECTED  
LEFT BRONCHIAL ARTERIES - CROSS TABULATION 
15 15
53.6% 53.6%
13 13
46.4% 46.4%
28 28
100.0% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
 Vessel Not Indentifie
Vessel Indentified
NO. OF LT BRONCHI
ARTERIES - ANG
Total
Vessel
Indentified
 NO. OF LT
BRONCHIAL
ARTERY-CT
Total
 
 
T-TEST 
Group Statistics
28 .75 .585 .111
28 1.54 .744 .141
28 .61 .737 .139
28 1.64 .488 .092
28 .29 .535 .101
28 .82 1.249 .236
28 .32 .548 .104
28 2.32 3.221 .609
DIAGNOSIS
ANGIO
CT
ANGIO
CT
ANGIO
CT
ANGIO
CT
NO. OF RT BRONCH
ARTERIES
NO. OF LT BRONCH
ARTERIES
NON BRONCHIAL
SYSTEMIC - RIGHT
NON BRONCHIAL
SYSTEMIC - LEFT
N Mean Std. Deviation
Std. Error
Mean
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INDEPENDENT SAMPLES TEST 
3.659 .061 -4.390 54 .000 -.786 .179 -1.145 -.427
-4.390 51.151 .000 -.786 .179 -1.145 -.426
8.249 .006 -6.198 54 .000 -1.036 .167 -1.371 -.701
-6.198 46.844 .000 -1.036 .167 -1.372 -.700
9.839 .003 -2.087 54 .042 -.536 .257 -1.050 -.021
-2.087 36.572 .044 -.536 .257 -1.056 -.015
39.940 .000 -3.239 54 .002 -2.000 .617 -3.238 -.762
-3.239 28.562 .003 -2.000 .617 -3.264 -.736
Equal varianc
assumed
Equal varianc
not assumed
Equal varianc
assumed
Equal varianc
not assumed
Equal varianc
assumed
Equal varianc
not assumed
Equal varianc
assumed
Equal varianc
not assumed
NO. OF RT BRONC
ARTERIES
NO. OF LT BRONC
ARTERIES
NON BRONCHIAL
SYSTEMIC - RIGH
NON BRONCHIAL
SYSTEMIC - LEFT
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
 
 
NPAR TESTS 
MANN-WHITNEY TEST 
Test Statisticsa
185.500 121.000 305.500 266.000
591.500 527.000 711.500 672.000
-3.862 -4.730 -1.692 -2.352
.000 .000 .091 .019
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed
NO. OF RT
BRONCHIAL
ARTERIES
NO. OF LT
BRONCHIAL
ARTERIES
NON
BRONCHIAL
SYSTEMIC -
RIGHT
NON
BRONCHIAL
SYSTEMIC -
LEFT
Grouping Variable: DIAGNOSISa. 
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DISCUSSION 
 
Since MDCT of the Chest for the search of bronchial and nonbronchial 
arteries revealed many other data regarding the diseased lung parenchyma, the data 
was analysed to find if the detection of the disease could lateralize the site of origin 
of hemoptysis.  It was found that the coronal Maximal intensity projection of the 
lungs was useful in depicting disease and disease process capable of producing 
hemoptysis was noted in all 28 cases.  The diseases were unilateral in 60.7% cases.  
However, since disease process capable of producing hemoptysis was noted in 
39.3% of cases, there is a need for another investigative modality to lateralize the 
side of bleed.   
When the MDCT findings of lung parenchymal disease were checked with 
hypertrophy of bronchial arteries on the right side, it was found to have a 
sensitivity of 88% and specificity of 72%. On the left side, the sensitivity was 
94.7% and specificity was 66.67 %.  On both sides, the positive and negative 
predictive values were more than 80%. The P value was found to be 0.001 on both 
sides, indicating that it was highly significant.   
Regarding the causative factors for hemoptysis, it was found that cavitary 
disease due to tuberculosis was the commonest (64.3%) followed by bronchiectasis 
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(57.1%).  A combination of cavity with bronchiectasis was noted in 28.6% of 
cases.   
Regarding the predictors for nonbronchial artery supply, the pleural 
thickness was assessed in every case.  It was found that significant pleural 
thickening (more than 3mm) was related with a non bronchial systemic supply.  On 
the right side, significant pleural thickening was noted to be 75% sensitive and 
81.25% specific for the detection of nonbronchial arterial supply.  On the left side, 
it was noted to be 92.86% sensitive and 78.57% specific for the detection of 
nonbronchial arterial supply.  On both sides, they were found to be statistically 
significant. 
Since the bronchial circulation is the major source of bronchial bleeding and 
because bronchial arteries vary considerably in their numbers and sites of origin, 
the anatomic characteristics of bronchial arteries ipsilateral to the side of bleeding 
were analyzed.  38 bronchial arteries were identified on conventional angiogram 
compared with 89 bronchial arteries by MDCT.  On an average, 3.18 bronchial 
arteries were detected per case by MDCT. Hence, the detection rate of bronchial 
arteries was found to be more than double by MDCT when compared with 
conventional angiography.  In MDCT, common trunk of origin of bronchial 
arteries was noted in 46.4% of patients including two patients who had 2 common 
trunks in them.  In contrast, these common trunks were identified in only 14.3% of 
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patients by conventional angiography.  MDCT detected 3.2 times the number of 
common trunks detected by conventional angiography.   
MDCT was able to identify at least one right and left bronchial artery in all 
28 cases, whereas conventional angiography was able to demonstrate right 
bronchial artery in only 75% of cases and left bronchial artery in only 60.7% of 
cases. 
When a search for bronchial arteries was made on MDCT, it was found that 
39% of cases had multiple right bronchial arteries and   64% of cases had multiple 
left bronchial arteries.  Four cases had triple right bronchial artery supply, whereas 
none cases had triple left bronchial supply.  Hypertrophied Right Bronchial artery 
(more than 1.5mm) was noted in 60.7% cases or 46.5% arteries.    Hypertrophied 
left bronchial artery was noted in 67.9% cases or 43.5% arteries. 
The level of origin of bronchial arteries in the Z- axis was clearly depicted in 
MDCT and was found to be between the D5 and D6 vertebral body level in 91% of 
right bronchial arteries and 84.8% of left bronchial arteries.  In all cases, the 
bronchial arteries on both sides were noted to originate between D4 and D7 
vertebral body level.  These results are in agreement with previous reports, which 
emphasized that more than 70% of bronchial arteries arise from the descending 
aorta. (60,116,117)  Whereas most authors describe the origins of bronchial 
arteries based on the level or range of thoracic vertebrae (60,116,117), new articles 
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(21,118) have found that this area of reference is wide and difficult to accurately 
identify at fluoroscopy. Using trachea as the anatomic reference, it found that all 
orthotopic right and left bronchial arteries arose at the level of or slightly lower 
than the tracheal carina, thus facilitating their selective catheterization.  The left 
main bronchial artery was found to be the best reference for locating the origin of 
bronchial arteries. The ostial position of the bronchial arteies in the axial plane was 
clearly depicted on MDCT and was found to be between 9 and 1’o clock position 
in right bronchial arteries.  They were most commonly noted between 9 and 10’o 
clock position (67.3%).  When the arteries with common trunk of origin were 
excluded, 96.4% of right bronchial arteries were found to have origin between 9 
and 10’o clock position in the axial plane.  Intercostobronchial origin of right 
bronchial artery was noted in 89.3% of right bronchial arteries.  No left bronchial 
artery had an intercostobronchial origin. 
The left bronchial arteries had their ostia between 9 and 2’o clock position, 
with 84.8% of left bronchial arteries arising between 11 and 1’o clock position.  
When the common trunk of origin of bronchial arteries was excluded, this figure 
rose to 87.1%.  These findings confirm that the majority of right bronchial arteries 
arise in the medial wall of the descending aorta, whereas most left bronchial 
arteries arise in the anterior wall of the descending aorta (18,21,61) 
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The right intercostobronchial arteries had their origin between D5 and D6 level in 
92% cases and their ostial position was between 9 and 10’o clock in 96% of cases.  
The common trunk of origin of bronchial arteries was noted to have origin between 
D5 and D6 level in 86.7% and were found to have their ostia between 11 and 1’o 
clock positon in 80% of arteries. 
Regarding the nonbronchial systemic arteries, it was found that these were 
more common on the left side (41 on left compared with 23 on right).  Because 
recurrent hemoptysis after a successful bronchial artery embolization may be 
related to the presence of a nonbronchial systemic arterial supply, one should 
emphasize the usefulness of its depiction with CT angiography prior to the second 
embolization session. Of particular importance is the subclavian artery and its 
branches (most commonly, the internal mammary artery) for upper-lobe bleeding 
and the inferior phrenic artery for lower-lobe bleeding (2,13,14,16,17,18, 120,30). 
However, numerous additional vessels may give rise to a nonbronchial systemic 
arterial supply to the lung, such as the branches of the axillary arteries, the 
intercostals arteries, or the hepatic and gastric arteries (9,11,126). The internal 
mammary artery was found to be supplying lung lesions when the adjoining 
pleural thickness was more than 3mm.  The size of the internal mammary artery 
was also assessed in all patients and it was found that a size more than 3mm 
diameter was associated with supply to the lung lesions.  The sensitivity and 
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specificity for this cut off of 3mm of internal mammary artery was 100% and this 
was found to be statistically highly significant. The average size of the 
hypertrophied internal mammary arteries was found to be 3.8mm.  Similarly, the 
inferior phrenic arteries were found to be hypertrophied and supplying lung lesions 
when a lower lobe lung lesion was associated with adjacent pleural thickening.  A 
cutoff of 2mm for the inferior phrenic arteries had a sensitivity of 75% and 
specificity of 91.67%.  The negative predictive value was high (95.6%)  This cut 
off of diameter for inferior phrenic artery was also found to be statistically 
significant. 
The ostial position of intercostals arteries on both side was also checked in 
all cases since they are one of the most common nonbronchial systemic arteries.  It 
was found that the ostial position of both normal and pathologic intercostal arteries 
between D4 and D7 level was very consistent, between 9 and 10’o clock position 
for all right intercostals arteries and between 6 and 7’o clock position for all left 
intercostals arteries. 
CT angiographic findings enabled direct selective catheterization of 
abnormal nonbronchial systemic artery in the vicinity of the bleeding site in 8 
patients. These results suggest that multi–detector row helical CT angiography can 
help in the planning of a focused and efficient nonbronchial systemic artery 
embolization, as was recently reported with single– detector row CT (20,21). 
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Consequently, thoracic aortography, an invasive procedure still recommended by 
many authors to improve the detection of arteries contributing to hemoptysis 
(2,126, 63) should be replaced with CT angiography. (21)   
Even though a direct comparison cannot be made in this study since it was a 
life threatening disease and it is against ethics to blind the study, when MDCT and 
conventional angiography were compared for the detection efficiency of bronchial 
and nonbronchial systemic arteries, it was found that the detection efficiency of 
MDCT was clearly better for the detection of bronchial and nonbronchial systemic 
arteries on both sides and the difference was found to be statistically significant. 
Because the most dreaded consequence of a bronchial artery embolization is 
inadvertent occlusion of spinal arteries, we included the search for an anterior 
spinal artery on curved MIPs of the cervicothoracic junction in all patients. The 
lack of identification of this vessel on CT and/or conventional angiograms in these 
patients precludes any conclusion regarding the accuracy of CT angiography in 
depicting this important collateral, which was present in about 5% of patients. 
(21,122)   
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CONCLUSION 
 
This study has showed that MDCT is an important diagnostic tool in the 
evaluation of hemoptysis, It aids in evaluation of the lung parenchyma, helps to 
diagnose the disease process, estimates the volume of lung parenchymal loss and 
detects pathologic bronchial and nonbronchial arteries.  The anatomy of the 
bronchial arteries has been proved to be clearly depicted in this study.  A new 
mode of reference for the axial localization of bronchial arteries by the clock 
method was used in this study and found to be very helpful in the selective 
catheterization of bronchial arteries. For z-axis (cranio-caudal) localization, it was 
found that the vertebral body level is a good reference level for comparison, but the 
use of the left main bronchus as a reference level was found to be more useful for 
the interventional radiologist.  
All the bronchial arteries were found to arise between D4 and D7 level and 
these arteries followed expected normal course.  Hence the definition of orthotopic 
bronchial arteries can include those arising from D4 and D7 level also instead of 
just D5-D6 level. The ostia of right bronchial artery was found to be commonly 
between 9 and 10’o clock position and left bronchial artery between 11 and 1’o 
clock position.  The intercostal arteries were also found to have a fixed ostial 
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position.  These data may be extremely useful for the interventional radiologist and 
helps to avoid thoracic aortography.  
The predictors for nonbronchial supply like a significant pleural thickening 
(3mm and above), hypertrophied internal mammary artery (3mm and above) and 
inferior phrenic artery (2mm and above) have been validated by this study.  
Multiple nonbronchial systemic arteries were detected in this study with as many 
as 12 arteries in a single patient and this indicates the need for a search for such 
arteries prior to embolotherapy in order to prevent recurrent hemoptysis.  With the 
multitude of uses and superiority over conventional angiography, MDCT has 
proved to be the single best pre embolotherapy investigative modality and can be 
considered as the gold standard for evaluation of life threatening hemoptysis.  This 
study will aid to evolve a new protocol for evaluation of life threatening 
hemoptysis, which is very common in our country because of tuberculosis and has 
the potential to save many lives. 
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PROFORMA 
Bleeding Vessels in Life Threatening Hemoptysis: Comparison of 64 Detector Row CT 
Angiography with Conventional Angiography Prior to Endovascular Management 
NAME:         PT. ID:  
AGE/SEX:              WT:  KG  DATE OF EVALUATION: 
HOSPITAL:                                                        WARD   HOSP. ID: 
ADMITTED ON:        DISCHARGED ON: 
HOME ADDRESS:        PH. NO: 
          
 
PRESENT HISTORY: 
Hemoptysis –  
No. of Episodes – 
Volume of Hemoptysis (Approx) - 
Physician Opinion of Threat to Life – 
Other Symptoms -  
ATT:   Regime - 
Date of Commencement -   Date of Completion -    Duration- 
PAST HISTORY: 
 
INVESTIGATIONS:  
Sputum -                                      Date:  
CT –          Date: 
 
Bronchoscopy –                      Date  
 
CXR -                                            Date  
CONSENT 
I do hereby give consent for the above 
mentioned study.  The risks involved were 
clearly explained to me. 
 
           (Signature )      Relation: 
 
 
 
CT PROTOCOL:                                             Date -       
Contrast Material – (350mg/dL) 
Rate – 5ml / Sec 
Canula – 18 G 
Commencement of Scan – Phase of peak arterial enhancement.  Automatic trigger with preset of 
100 HU     at   Arch of  Aorta 
Factors - 140 kV, 70 to 120 mAs 
Rotation Time  - 0.5 Sec 
Collimation – 0.75 mm 
Pitch – 0.5 
Scan Duration – 
Height of Volume Scanned -   
Complications -  
 
CT  FINDINGS: 
Bronchial Vessels Identified –  
Site of Origin of Vessels –  
Location of Ostia –  
Extra pulmonary Course of Vessel – 
Intra pulmonary Course of Vessel – 
Width of Vessel –  
Tortuosity –  
Parenchymal Staining –  
Systemic – Pulmonary Arterial Shunting -  
Contrast Extravasation at points of bleeding – 
Identification of Spinal Arteries - 
 
 
 
 
 
ANGIOGRAPHY METHODOLOGY:                                           Date - 
Time interval between CT and Angio -  
Approach –  
Contrast Injected – 
Volume of Contrast Used -   
Time taken for Study – 
Complications -  
ANGIOGRAPHY FINDINGS: 
Bronchial Vessels Identified –  
Site of Origin of Vessels –  
Location of Ostia –  
Extra pulmonary Course of Vessel – 
Intra pulmonary Course of Vessel – 
Width of Vessel –  
Tortuosity –  
Parenchymal Staining –  
Systemic – Pulmonary Arterial Shunting -  
Contrast Extravasation at points of bleeding – 
Identification of Spinal Arteries -  
EMBOLISATION METHODOLOGY: 
Vessel Embolised –  
Volume of Embolus –        Material used - Gelfoam 
Time Taken –  
Complications –  
Post Embolisation Angiography Findings – 
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PT ID NAME AGE SEX
CT AND 
ANGIO 
INTERVAL 
(DAYS)
HEMOPTYS
IS IN 3 
DAYS (ML)
TB 
HISTORY
EMBOLIZ
ATION 
NO. OF RT 
BRONCHIAL 
ARTERIES IN 
ANGIO
ANGIO NBS  
RIGHT
NO. OF LT 
BRONCHIAL 
ARTERIES IN 
ANGIO
ANGIO NBS  
LEFT
SIDE OF MAJOR 
DISEASE 
PROCESS IN 
CORONAL MIP 
SLAB
MAX PL 
THICK 
RIGHT 
MM
MAX PL 
THICK 
LEFT  
MM
1 NILAVALAGI 40 F 1 300 YES YES 1 YES 0 NO RIGHT 12.8 0
2 NETHAJI 38 M 2 600 YES YES 1 NO 0 NO BILATERAL 7.7 0
3 MANI 60 M 6 100 NO NO 0 NO 0 NO LEFT 0 6
4 CHAKRAVARTHY 52 M 2 200 YES YES 1 NO 0 NO RIGHT 10.3 0
5 RAJESWARI 55 F 4 120 YES YES 1 NO 1 YES BILATERAL 0 4.3
6 RAJENDRAN 18 M 5 50 NO NO 0 NO 0 NO BILATERAL 0 0
7 GUNASEKARAN 22 M 2 150 YES YES 2 NO 2 NO LEFT 0 0
8 RAMESH 27 M 1 90 YES YES 0 NO 1 YES LEFT 0 5.7
9 GOVINDAN 63 M 1 400 YES YES 1 YES 0 NO BILATERAL 5.2 2.3
10 RAMESH 33 M 3 500 YES YES 1 NO 1 NO BILATERAL 3.8 6.7
11 VENKATRAMAN 23 M 4 15 YES YES 0 NO 2 YES LEFT 0 5.9
12 SALAVUDDIN 33 M 3 150 YES YES 1 YES 0 NO RIGHT 3 0
13 NAGARAJ 38 M 1 100 YES YES 0 NO 1 YES BILATERAL 2.4 6.4
14 NATESAN 50 M 3 150 YES YES 0 NO 1 NO LEFT 2 7
 
 
 
PT ID
TOTAL NO. 
OF RT 
BRONCHIAL 
ARTERY IN 
MDCT
ORIGIN OF 
RIGHT 
BRONCHIAL 
ARTERY
OSTIA OF 
RT 
BRONCHI
AL 
ARTERY 
OSTIA OF 
COMMON 
TRUNK 
DIA OF 
RIGHT 
BRONCHIAL 
ARTERY
NO. OF 
RIGHT 
NBS
TOTAL NO. 
OF LT 
BRONCHIAL 
ARTERY IN 
MDCT
ORIGIN OF 
LEFT 
BRONCHIAL 
ARTERY 
OSTIA OF 
LEFT 
BRONCHIAL 
DIA OF LEFT 
BRONCHIAL 
ARTERY
NO. OF 
LEFT 
NBS
1 3 D4/D5/D5 9 AND 9 12
2.0MM/2.7MM/
1.2MM
2 1 D5 12 1.3MM 0
2 2 D5/D6 9 12
1.6MM / 
0.7MM
0 2 D6/D7 12 AND 12 0.7MM/0.9MM 0
3 1 D5 9 0 1.1MM 0 2 D4/D5 12 AND 12 1.1MM/0.9MM 0
4 1 D5 9 0 4.8MM 1 2 D5/D6 11 AND 12 1.8MM/0.8MM 0
5 1 D5 9 0 1.8MM 0 2 D5/D5 11 AND 12 1.5MM/1.1MM 1
6 1 D7 0 12 1.4MM 0 2 D5/D7 11 AND 12 1.5MM/1.6MM 0
7 1 D5 0 9 2.1MM 0 2 D5/D5 9AND9 0.9MM/1.8MM 0
8 1 D6 9 0 0.7MM 0 1 D5 11 2.9MM 2
9 2 D5/D6 9 12 1.2MM/1.3MM 1 2 D6/D6  12 AND 1  1.9MM/1.1MM 0
10 1 D6 9 0 2.3MM 0 1 D6 12 2.2MM 1
11 1 D5 9 0 1MM 0 2 D7/D7 1AND 12 2.3MM/1.2MM 4
12 1 D6 9 0 2.2MM 1 1 D6 11 0.8MM 0
13 1 D6 9 0 2.5MM 0 1 D6 1 1.7MM 2
14 1 D6 9 0 1.7MM 0 1 D5 1 2.2MM 1
 
 
 
 
 
 
 
 
 
 
PT ID NAME AGE SEX
CT AND 
ANGIO 
INTERVAL 
(DAYS)
HEMOPTYS
IS IN 3 
DAYS (ML)
TB 
HISTORY
EMBOLIZ
ATION 
NO. OF RT 
BRONCHIAL 
ARTERIES IN 
ANGIO
ANGIO NBS  
RIGHT
NO. OF LT 
BRONCHIAL 
ARTERIES IN 
ANGIO
ANGIO NBS  
LEFT
SIDE OF MAJOR 
DISEASE 
PROCESS IN 
CORONAL MIP 
SLAB
MAX PL 
THICK 
RIGHT 
MM
MAX PL 
THICK 
LEFT  
MM
15 SARAVANAN 65 M 4 100 YES NO 0 NO 0 NO LEFT 0 6
16 PARTHASARATHY 65 M 3 200 YES YES 1 NO 1 NO BILATERAL 4.2 4.1
17 SAKTHIVEL 30 M 3 50 YES YES 1 NO 1 NO LEFT 1.5 4.6
18 SANTHAKUMAR 45 M 5 500 YES YES 1 NO 0 NO RIGHT 5 0
19 RAJALAKSHMI 38 F 2 10 YES YES 0 2 NO LEFT 0 2.4
20 GANGAIAH 40 M 5 150 YES YES 1 YES 1 NO BILATERAL 3.7 10.5
21 SURESHKUMAR 23 M 5 1500 YES YES 2 NO 0 NO RIGHT 3 0
22 ELUMALAI 45 M 3 1000 YES YES 1 YES 2 NO BILATERAL 4.3 7.8
23 ASCIFF 18 M 3 300 NO YES 1 NO 0 NO RIGHT 2.1 0
24
THIRUNAVUKKARAS
U
52 M 4 450 YES YES 1 NO 0 YES LEFT 0 11.6
25 PALANI 58 M 2 500 NO YES 1 NO 0 NO BILATERAL 2.8 6.9
26 KANNAN 46 M 2 1200 YES YES 1 YES 0 YES BILATERAL 15.8 12.9
27 SIMON 28 M 1 900 YES YES 1 YES 0 NO RIGHT 2.1 4.3
28 KANNAN 22 M 3 300 NO YES 0 NO 1 YES LEFT 0 0
 
 
 
PT ID
TOTAL NO. 
OF RT 
BRONCHIAL 
ARTERY IN 
MDCT
ORIGIN OF 
RIGHT 
BRONCHIAL 
ARTERY
OSTIA OF 
RT 
BRONCHI
AL 
ARTERY 
OSTIA OF 
COMMON 
TRUNK 
DIA OF 
RIGHT 
BRONCHIAL 
ARTERY
NO. OF 
RIGHT 
NBS
TOTAL NO. 
OF LT 
BRONCHIAL 
ARTERY IN 
MDCT
ORIGIN OF 
LEFT 
BRONCHIAL 
ARTERY 
OSTIA OF 
LEFT 
BRONCHIAL 
DIA OF LEFT 
BRONCHIAL 
ARTERY
NO. OF 
LEFT 
NBS
15 1 D5 9 0 1.3MM 0 2 D6/D5 11 AND 12 0.8MM/1.5MM 5
16 2 D6/D5 9 9
1.5MM / 
2.1MM 
0 1 D5 9   1.4MM 0
17 3 D5/D5/D6 10 12 AN 1
1MM/1MM/1.1
MM
0 2 D5/D6 12 AND 1
1.9MM  / 
1.9MM 
4
18 1 D5 9 0 1.7MM 1 1 D6 12 1.0MM 0
19 1 D6 9 0 0.9MM 0 2 D5/D6 9AND1 1.5MM/1.3MM 0
20 1 D5 9 0 1.8MM 1 2 D5/D5 10AND1 1.6MM/1.1MM 4
21 2 D7/D6 9 12 1.4MM/1.3MM 3 1 D6 12  0.9MM 0
22 1 D5 0 12 2.0MM 5 2 D5/D6 12 AND 1
  1.6MM / 1. 3 
MM
6
23 3 D5/D6/D5 9 AND 1 1
1.6MM / 
1.5MM/ 1.4MM
1 1 D5 12   1.1MM 0
24 3 D5/D5/D6 9 11 AND 12
1.3MM/0.8MM/
0.8MM
0 2 D5  /D6 11 AND 12
 1.3MM /  
1.5MM 
5
25 2 D5/D5 9 11
3.9MM / 
1.2MM
2 2 D5/D6 11 AND 11
3.4MM / 
1.0MM
2
26 1 D5  9 0 2.4MM 2 2 D4 /D6 12 AND 1 1.7MM/1.4MM 3
27 2 D5/D5 9 AND 10 0 3.1MM/ 0.9MM 3 2 D6/D6 12 AND 1 1.1MM/1.0MM 0
28 2 D4/D5 9 9
 1.4MM/ 
0.6MM
0 2 D4/D6 9 AND 2 1.3MM/1.6MM 1
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